1652 Fusen Pharmaceutical Co., Ltd. HKEX · China

Fusen Pharmaceutical Co. (1652) news

Fusen Pharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1652, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Fusen Pharmaceutical Co. news

We have not published a story on Fusen Pharmaceutical Co. yet. When there is news, it will appear here.

Questions about Fusen Pharmaceutical Co.

What is the ticker symbol of Fusen Pharmaceutical Co.?

Fusen Pharmaceutical Co., Ltd. trades under the ticker 1652 on HKEX.

Where is Fusen Pharmaceutical Co. listed?

Fusen Pharmaceutical Co., Ltd. is listed on HKEX.

Which country or territory is Fusen Pharmaceutical Co. listed under?

Our directory records Fusen Pharmaceutical Co., Ltd. under China.

What does Fusen Pharmaceutical Co. do?

Our directory classifies Fusen Pharmaceutical Co., Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Fusen Pharmaceutical Co.?

The ISIN recorded for Fusen Pharmaceutical Co., Ltd. is KYG370981030.

Does aibio.space cover Fusen Pharmaceutical Co.?

aibio.space lists Fusen Pharmaceutical Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Fusen Pharmaceutical Co.?

Companies in our directory listed in the same country and business area as Fusen Pharmaceutical Co.: Guangzhou Baiyunshan Pharmaceutical Holdings Company, Jiangsu Jibeier Pharmaceutical Co., China SXT Pharmaceuticals, Renhe Pharmacy Co., Sunflower Pharmaceutical Group Co., Joincare Pharmaceutical Group Industry Co..

Investor discussion: Fusen Pharmaceutical Co.

Members talk about Fusen Pharmaceutical Co. (1652). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Fusen Pharmaceutical Co., newest first. Each line links the filing it comes from.

Oct 8, 2026Mergers
Transaction under the Listing Rules: FURTHER EXTENSION OF COMPLETION DATE OF MAJOR TRANSACTION IN RELATION TO DEEMED DISPOSAL OF EQUITY INTEREST IN HENAN FUSEN PHARMACEUTICAL COMPANY LIMITED. Source
Jul 30, 2026Mergers
Transaction under the Listing Rules: EXTENSION OF COMPLETION DATE OF MAJOR TRANSACTION IN RELATION TO DEEMED DISPOSAL OF EQUITY INTEREST IN HENAN FUSEN PHARMACEUTICAL COMPANY LIMITED. Source
Jun 22, 2026Mergers
Transaction under the Listing Rules: MAJOR TRANSACTION IN RELATION TO DEEMED DISPOSAL OF EQUITY INTEREST IN HENAN FUSEN PHARMACEUTICAL COMPANY LIMITED. Source
Jun 18, 2026Mergers
Transaction under the Listing Rules: MAJOR TRANSACTION IN RELATION TO DEEMED DISPOSAL OF EQUITY INTEREST IN HENAN FUSEN PHARMACEUTICAL COMPANY LIMITED. Source
Apr 30, 2026Financings
Share or debt issue: PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND SELL TREASURY SHARES AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS, RE-APPOINTMENT OF AUDITORS AND NOTICE OF ANNUAL GENERAL MEETING. Source
Oct 27, 2025Mergers
Transaction under the Listing Rules: SUPPLEMENTAL ANNOUNCEMENT DISCLOSEABLE TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE EQUITY INTERESTS IN HENAN FUSEN INTELLIGENT ENERGY CONSERVATION TECHNOLOGY COMPANY LIMITED. Source
Sep 21, 2025Mergers
Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE EQUITY INTERESTS IN HENAN FUSEN INTELLIGENT ENERGY CONSERVATION TECHNOLOGY COMPANY LIMITED. Source
Apr 28, 2025Financings
Share or debt issue: PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND SELL TREASURY SHARES AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS, RE-APPOINTMENT OF AUDITORS AND NOTICE OF ANNUAL GENERAL MEETING. Source

Press releases

Headlines of Fusen Pharmaceutical Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it.

Oct 8, 2026HKEXnews
FURTHER EXTENSION OF COMPLETION DATE OF MAJOR TRANSACTION IN RELATION TO DEEMED DISPOSAL OF EQUITY INTEREST IN HENAN FUSEN PHARMACEUTICAL COMPANY LIMITED
Sep 30, 2026HKEXnews
Notification Letter to Non-Registered Holders and Reply Form - Notice of Publication of Interim Report
Sep 30, 2026HKEXnews
Notification Letter to Registered Shareholders and Reply Form - Notice of Publication of Interim Report
Aug 31, 2026HKEXnews
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026
Aug 3, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT SELECTION RESULTS OF NATIONAL CENTRALISED MEDICINES PROCUREMENT
Jul 30, 2026HKEXnews
EXTENSION OF COMPLETION DATE OF MAJOR TRANSACTION IN RELATION TO DEEMED DISPOSAL OF EQUITY INTEREST IN HENAN FUSEN PHARMACEUTICAL COMPANY LIMITED
Jul 10, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT "DOXAZOSIN MESYLATE EXTENDED-RELEASE TABLETS" APPROVED FOR MARKETING
Jul 9, 2026HKEXnews
POLL RESULT OF THE EXTRAORDINARY GENERAL MEETING HELD ON 9 JULY 2026
Jun 26, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT "PERAMIVIR INJECTION" APPROVED FOR MARKETING
Jun 23, 2026HKEXnews
Notification Letter to Non-Registered Holders and Reply Form - Notice of Publication of Circular of Extraordinary General Meeting
Jun 23, 2026HKEXnews
Notification Letter to Registered Shareholders and Reply Form - Notice of Publication of Circular and Proxy Form of Extraordinary General Meeting
Jun 22, 2026HKEXnews
Documents on Display
Jun 22, 2026HKEXnews
NOTICE OF THE EXTRAORDINARY GENERAL MEETING
Jun 22, 2026HKEXnews
MAJOR TRANSACTION IN RELATION TO DEEMED DISPOSAL OF EQUITY INTEREST IN HENAN FUSEN PHARMACEUTICAL COMPANY LIMITED
Jun 18, 2026HKEXnews
BOOK CLOSURE PERIOD FOR THE EXTRAORDINARY GENERAL MEETING
Jun 16, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT "PIRACETAM INJECTION" APPROVED FOR MARKETING
Jun 8, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT "AGOMELATINE TABLETS" APPROVED FOR MARKETING
May 29, 2026HKEXnews
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 29 MAY 2026
May 11, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT "LORNOXICAM FOR INJECTION" APPROVED FOR MARKETING
Apr 30, 2026HKEXnews
Notification Letter to Non-Registered Holders and Reply Form - Notice of Publication of Annual Report 2025 and Circular of Annual General Meeting

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:1652 on TradingView.

Listing details

Company: Fusen Pharmaceutical Co., Ltd.
Ticker: 1652
Listing: HKEX
Country or territory: China
Business scope: Pharmaceuticals: Major
ISIN: KYG370981030
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction